The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates
Cardiology · 2025
DOI: 10.1159/000543400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2025. Verfasst von Eran Yerushalmi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Lung Transplantation, Coronary Artery Disease, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Lung transplantation (LT) is a lifesaving procedure in patients with end stage lung failure. The prevalence of coronary artery disease (CAD) in patients with lung disease is comparably high, and coronary angiography is widely used for coronary anatomy assessment prior to LT. Detection of significant CAD usually results in revascularization to minimize posttransplant cardiovascular events. We aim to examine the prognostic significance of CAD interventions on LT candidates pre- and post-LT.
Methods
From a retrospective registry of 450 LT candidates undergoing cardiac catheterization during 2014–2019, patients were assessed for the presence of significant CAD and percutaneous coronary intervention. The primary outcome was defined as occurrence of major advance cardiac events (MACE) in LT candidates while on the waiting list. MACE comprising of cardiovascular mortality, nonfatal myocardial infarction, target-vessel revascularization, and coronary artery bypass graft surgery. Secondary outcomes were the occurrence of MACE posttransplant according to the coronary intervention status.
Results
MACE was recorded in 22 LT candidates, with a higher incidence in the intervention group compared to the nonintervention group (8.3% vs. 4.4%, p = 0.007). 28.6% of MACE events in the intervention group occurred in the first month after intervention. Cardiovascular mortality accounted for 8.6% of all deaths, without significant difference between the intervention and nonintervention group (16.0% vs. 7.2%, p = 0.155). The rates of MACE post-LT were mildly and nonsignificantly increased in the intervention group compared to the nonintervention group (11.1% vs. 4.5%, p = 0.18).
Conclusion
Pre-LT routine coronary intervention does not necessarily protect patients from experiencing MACE while on the waiting list or post-LT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel, kskalsky@gmail.com.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, kskalsky@gmail.com.
Zitieren
APA
Yerushalmi, E., Abu, T., Hasdai, D., Aviv, Y., Kornowski, R., & Skalsky, K. (2025). The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates. Cardiology. https://doi.org/10.1159/000543400
Vancouver
Yerushalmi E, Abu T, Hasdai D, Aviv Y, Kornowski R, Skalsky K. The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates. Cardiology. 2025. doi:10.1159/000543400
BibTeX
@article{Yerushalmi2025,
author = {Yerushalmi, Eran and Abu, Tal and Hasdai, David and Aviv, Yaron and Kornowski, Ran and Skalsky, Keren},
title = {The Prognostic Significance of Coronary Artery Disease Interventions in Lung Transplant Candidates},
journal = {Cardiology},
year = {2025},
doi = {10.1159/000543400}
}
EUVIMED